Kim, Y. A., Mellen, M., Kizil, C., & Santa‐Maria, I. (2023). Mechanisms linking cerebrovascular dysfunction and tauopathy: Adding a layer of epiregulatory complexity. British Journal of Pharmacology, 181(6), 879–895. Portico. https://doi.org/10.1111/bph.16280

Hill, R., Sanchez, J., Lemel, L., Antonijevic, M., Hosking, Y., Mistry, S. N., Kruegel, A. C., Javitch, J. A., Lane, J. R., & Canals, M. (2023). Assessment of the potential of novel and classical opioids to induce respiratory depression in mice. British Journal of Pharmacology, 180(24), 3160–3174. Portico. https://doi.org/10.1111/bph.16199

Armstrong, J. F., Campo, B., Alexander, S. P. H., Arendse, L. B., Cheng, X., Davenport, A. P., Faccenda, E., Fidock, D. A., Godinez‐Macias, K. P., Harding, S. D., Kato, N., Lee, M. C. S., Luth, M. R., Mazitschek, R., Mittal, N., Niles, J. C., Okombo, J., Ottilie, S., Pasaje, C. F. A., … Davies, J. A. (2023). Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38. British Journal of Pharmacology, 180(15), 1899–1929. Portico. https://doi.org/10.1111/bph.16144

Hill, R., Kruegel, A. C., Javitch, J. A., Lane, J. R., & Canals, M. (2022). The respiratory depressant effects of mitragynine are limited by its conversion to 7‐OH mitragynine. British Journal of Pharmacology, 179(14), 3875–3885. Portico. https://doi.org/10.1111/bph.15832

Patel, M., Matti, C., Grimsey, N. L., Legler, D. F., Javitch, J. A., Finlay, D. B., & Glass, M. (2022). Delineating the interactions between the cannabinoid CB2 receptor and its regulatory effectors; β‐arrestins and GPCR kinases. British Journal of Pharmacology, 179(10), 2223–2239. Portico. https://doi.org/10.1111/bph.15748